{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:54:24Z","timestamp":1791219264044,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,6]]},"DOI":"10.7759\/cureus.89488","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:34:03Z","timestamp":1754498043000},"source":"Crossref","is-referenced-by-count":4,"title":["Inflammation-Driven Lipid Suppression in Hospitalized Patients: Insights Into the Inflammatory Lipid Paradox From a Retrospective Study"],"prefix":"10.7759","author":[{"given":"Kyle E","family":"Thurmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha G","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Effect of inflammation and infection on lipids and lipoproteins","author":"Feingold KR","year":"2025","unstructured":"Feingold KR, Grunfeld C. Effect of inflammation and infection on lipids and lipoproteins. Endotext. Feingold KR, Ahmed SF, Anawalt B, et al. (ed): MDText.com, Inc., South Dartmouth, MA; 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e328304b65f","article-title":"Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus","volume":"19","author":"Haque S","year":"2008","unstructured":"Haque S, Mirjafari H, Bruce IN. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Curr Opin Lipidol. 2008, 19:338-43. 10.1097\/MOL.0b013e328304b65f","journal-title":"Curr Opin Lipidol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.01.015","article-title":"Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment","volume":"38","author":"Steiner G","year":"2009","unstructured":"Steiner G, Urowitz MB. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment. Semin Arthritis Rheum. 2009, 38:372-81. 10.1016\/j.semarthrit.2008.01.015","journal-title":"Semin Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca R","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, et al.. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017, 76:17-28. 10.1136\/annrheumdis-2016-209775","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-014-0497-6","article-title":"Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?","volume":"15","author":"Bag-Ozbek A","year":"2015","unstructured":"Bag-Ozbek A, Giles JT. Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?. Curr Allergy Asthma Rep. 2015, 15:497. 10.1007\/s11882-014-0497-6","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.016507","article-title":"Anti-inflammatory HDL function, incident cardiovascular events, and mortality: a secondary analysis of the JUPITER randomized clinical trial","volume":"9","author":"Ajala ON","year":"2020","unstructured":"Ajala ON, Demler OV, Liu Y, et al.. Anti-inflammatory HDL function, incident cardiovascular events, and mortality: a secondary analysis of the JUPITER randomized clinical trial. J Am Heart Assoc. 2020, 9:e016507. 10.1161\/JAHA.119.016507","journal-title":"J Am Heart Assoc"},{"key":"ref7","article-title":"Lipid profiles among US elderly with untreated rheumatoid arthritis--the third National Health and Nutrition Examination Survey","volume":"32","author":"Choi HK","year":"2005","unstructured":"Choi HK, Seeger JD. Lipid profiles among US elderly with untreated rheumatoid arthritis--the third National Health and Nutrition Examination Survey. J Rheumatol. 2005, 32:2311-6.","journal-title":"J Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/ar1952","article-title":"Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study","volume":"8","author":"Georgiadis AN","year":"2006","unstructured":"Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, Drosos AA. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study. Arthritis Res Ther. 2006, 8:R82. 10.1186\/ar1952","journal-title":"Arthritis Res Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta JA","year":"2008","unstructured":"Avi\u00f1a-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008, 59:1690-7. 10.1002\/art.24092","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000093381.57779.67","article-title":"C-reactive protein: a simple test to help predict risk of heart attack and stroke","volume":"108","author":"Ridker PM","year":"2003","unstructured":"Ridker PM. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 2003, 108:e81-5. 10.1161\/01.CIR.0000093381.57779.67","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000053731.05365.5a","article-title":"Coming of age of C-reactive protein: using inflammation markers in cardiology","volume":"107","author":"Yeh ET","year":"2003","unstructured":"Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003, 107:370-1. 10.1161\/01.cir.0000053731.05365.5a","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000053730.47739.3c","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker PM","year":"2003","unstructured":"Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003, 107:363-9. 10.1161\/01.cir.0000053730.47739.3c","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-004-0438-0","article-title":"Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation","volume":"25","author":"Dursuno\u011flu D","year":"2005","unstructured":"Dursuno\u011flu D, Evreng\u00fcl H, Polat B, Tanriverdi H, Cobankara V, Kaftan A, Kili\u00e7 M. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int. 2005, 25:241-5. 10.1007\/s00296-004-0438-0","journal-title":"Rheumatol Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02307-8","article-title":"Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?","volume":"22","author":"Fern\u00e1ndez-Ortiz AM","year":"2020","unstructured":"Fern\u00e1ndez-Ortiz AM, Ortiz AM, P\u00e9rez S, et al.. Effects of disease activity on lipoprotein levels in patients with early arthritis: can oxidized LDL cholesterol explain the lipid paradox theory?. Arthritis Res Ther. 2020, 22:213. 10.1186\/s13075-020-02307-8","journal-title":"Arthritis Res Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-015-0069-0","article-title":"TNF-alpha and IL-6 inhibit apolipoprotein A-IV production induced by linoleic acid in human intestinal Caco2 cells","volume":"12","author":"Li X","year":"2015","unstructured":"Li X, Xu M, Liu M, Ji Y, Li Z. TNF-alpha and IL-6 inhibit apolipoprotein A-IV production induced by linoleic acid in human intestinal Caco2 cells. J Inflamm (Lond). 2015, 12:22. 10.1186\/s12950-015-0069-0","journal-title":"J Inflamm (Lond)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03823-z","article-title":"The potential impact of inflammation on the lipid paradox in patients with acute myocardial infarction: a multicenter study","volume":"22","author":"Zeng G","year":"2024","unstructured":"Zeng G, Zhang C, Song Y, et al.. The potential impact of inflammation on the lipid paradox in patients with acute myocardial infarction: a multicenter study. BMC Med. 2024, 22:599. 10.1186\/s12916-024-03823-z","journal-title":"BMC Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076426","article-title":"The role of cytokines in cholesterol accumulation in cells and atherosclerosis progression","volume":"24","author":"Markin AM","year":"2023","unstructured":"Markin AM, Markina YV, Bogatyreva AI, Tolstik TV, Chakal DA, Breshenkov DG, Charchyan ER. The role of cytokines in cholesterol accumulation in cells and atherosclerosis progression. Int J Mol Sci. 2023, 24:6426. 10.3390\/ijms24076426","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/pl00011174","article-title":"Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis","volume":"19","author":"Lee YH","year":"2000","unstructured":"Lee YH, Choi SJ, Ji JD, Seo HS, Song GG. Lipoprotein(a) and lipids in relation to inflammation in rheumatoid arthritis. Clin Rheumatol. 2000, 19:324-5. 10.1007\/pl00011174","journal-title":"Clin Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04616-2","article-title":"The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk","volume":"40","author":"Venetsanopoulou AI","year":"2020","unstructured":"Venetsanopoulou AI, Pelechas E, Voulgari PV, Drosos AA. The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk. Rheumatol Int. 2020, 40:1181-91. 10.1007\/s00296-020-04616-2","journal-title":"Rheumatol Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.135871","article-title":"Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease","volume":"70","author":"Myasoedova E","year":"2011","unstructured":"Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011, 70:482-7. 10.1136\/ard.2010.135871","journal-title":"Ann Rheum Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.306471","article-title":"From lipids to inflammation: new approaches to reducing atherosclerotic risk","volume":"118","author":"Shapiro MD","year":"2016","unstructured":"Shapiro MD, Fazio S. From lipids to inflammation: new approaches to reducing atherosclerotic risk. Circ Res. 2016, 118:732-49. 10.1161\/CIRCRESAHA.115.306471","journal-title":"Circ Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.124.319983","article-title":"Immune-mediated inflammatory diseases, dyslipidemia, and cardiovascular risk: a complex interplay","volume":"44","author":"Wilkinson MJ","year":"2024","unstructured":"Wilkinson MJ, Shapiro MD. Immune-mediated inflammatory diseases, dyslipidemia, and cardiovascular risk: a complex interplay. Arterioscler Thromb Vasc Biol. 2024, 44:2396-406. 10.1161\/ATVBAHA.124.319983","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/398581-inflammation-driven-lipid-suppression-in-hospitalized-patients-insights-into-the-inflammatory-lipid-paradox-from-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:34:03Z","timestamp":1754498043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/398581-inflammation-driven-lipid-suppression-in-hospitalized-patients-insights-into-the-inflammatory-lipid-paradox-from-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.89488","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,6]]}}}